Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Breast cancer: combining bevacizumab with chemotherapy--from maintenance to second-line treatment.

× No keyword cloud information.

2 in total

1. Maintenance capecitabine and bevacizumab versus bevacizumab alone after initial first-line bevacizumab and docetaxel for patients with HER2-negative metastatic breast cancer (IMELDA): a randomised, open-label, phase 3 trial.

Authors: Joseph Gligorov; Dinesh Doval; José Bines; Emilio Alba; Paulo Cortes; Jean-Yves Pierga; Vineet Gupta; Rômulo Costa; Stefanie Srock; Sabine de Ducla; Ulrich Freudensprung; Giorgio Mustacchi
Journal: Lancet Oncol Date: 2014-09-28 Impact factor: 41.316

2. Bevacizumab plus chemotherapy versus chemotherapy alone as second-line treatment for patients with HER2-negative locally recurrent or metastatic breast cancer after first-line treatment with bevacizumab plus chemotherapy (TANIA): an open-label, randomised phase 3 trial.

Authors: Gunter von Minckwitz; Fabio Puglisi; Javier Cortes; Eduard Vrdoljak; Norbert Marschner; Christoph Zielinski; Cristian Villanueva; Gilles Romieu; István Lang; Eva Ciruelos; Michele De Laurentiis; Corinne Veyret; Sabine de Ducla; Ulrich Freudensprung; Stefanie Srock; Joseph Gligorov
Journal: Lancet Oncol Date: 2014-09-28 Impact factor: 41.316

2 in total

1 in total

Review 1. Anti-vascular endothelial growth factor therapy in breast cancer.

Authors: Tina Bøgelund Kristensen; Malin L T Knutsson; Markus Wehland; Britt Elmedal Laursen; Daniela Grimm; Elisabeth Warnke; Nils E Magnusson
Journal: Int J Mol Sci Date: 2014-12-11 Impact factor: 5.923

1 in total